Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2022.0338
Abstract: Importance Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been widely recommended for glucose control and cardiovascular risk reduction in patients with type 2 diabetes, and more recently, for weight loss. However, the associations of GLP-1… read more here.
Keywords: biliary diseases; risk gallbladder; use; gallbladder biliary ... See more keywords
Increasing gallstone disease prevalence and associations with gallbladder and biliary tract mortality in the US
Sign Up to like & getrecommendations! Published in 2023 at "Hepatology"
DOI: 10.1097/hep.0000000000000264
Abstract: Background and Aims: We examined gallbladder and biliary tract mortality predictors in the US National Health and Nutrition Examination Survey (NHANES), 1988-1994, with 31 years of linked mortality data, and gallstone disease prevalence trends and… read more here.
Keywords: disease; mortality; gallbladder biliary; gallstone disease ... See more keywords
Global burden of gallbladder and biliary diseases: A systematic analysis for the Global Burden of Disease Study 2019
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.15859
Abstract: Gallbladder and biliary diseases (GBDs) are one of the most prevalent medical issues in the digestive system. This study was designed to describe the characteristics of prevalence, death, and disability‐adjusted life years (DALYs) of GBDs… read more here.
Keywords: study 2019; gallbladder biliary; biliary diseases; global burden ... See more keywords
Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes Care"
DOI: 10.2337/dc19-0415
Abstract: OBJECTIVE To explore gallbladder- and biliary tract–related events reported for the liraglutide and placebo groups in the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial. RESEARCH DESIGN AND METHODS LEADER… read more here.
Keywords: gallbladder biliary; gallbladder; acute gallbladder; biliary disease ... See more keywords
The increasing incidence and high body mass index-related burden of gallbladder and biliary diseases–A results from global burden of disease study 2019
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.1002325
Abstract: Background Gallbladder and biliary diseases are common gastrointestinal conditions associated with huge socioeconomic costs and are considered risk factors for cardiovascular diseases and digestive system cancers. The prevalence and incidence of gallbladder and biliary diseases… read more here.
Keywords: biliary diseases; high bmi; incidence; gallbladder biliary ... See more keywords